Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Medivir AB 

Lunastigen 7

Huddinge    141 44  Sweden
Phone: 46-8-608-3100 Fax: 46-8-608-3199




GlaxoSmithKline (North Carolina) 

Peptimmune, Inc.  Development agreement for inhibitors of Cathepsin S for autoimmune and allergic diseases.

 Company News
Medivir AB (MVRBF): New Data On Simeprevir Presented At The Conference Of The Asian Pacific Association For The Study Of The Liver 3/16/2015 12:54:28 PM
Medivir AB (MVRBF) Capital Markets Meeting On 26 March 2015 3/12/2015 12:50:33 PM
New Members of Medivir AB (MVRBF)’s Management Group 3/2/2015 10:50:57 AM
Medivir AB (MVRBF): Financial Statement, January – December 2014 2/27/2015 11:30:10 AM
Presentation Of The Result Of Medivir AB (MVRBF)’s Voluntary Redemption Programme 2/27/2015 10:22:34 AM
Medivir AB (MVRBF)’s Nomination Committee Proposes New Board Of Directors Ahead Of 2015 AGM 2/18/2015 10:48:09 AM
Final Terms For Medivir AB (MVRBF)’s Voluntary Redemption Programme 1/30/2015 11:01:52 AM
Medivir AB (MVRBF)’s CEO Increases His Shareholding In The Company 1/27/2015 12:47:31 PM
Medivir AB (MVRBF) Makes Change Within The Management Team 1/21/2015 11:07:48 AM
Medivir AB (MVRBF): OLYSIO® Sales During The Fourth Quarter 2014 1/20/2015 11:35:30 AM